Patents by Inventor Mitchell Cheung

Mitchell Cheung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Malignant Mesothelioma Susceptibility As A Result Of Germline Leucine-Rich Repeat Kinase 2 (LRRK2) Alterations
    Publication number: 20240191304
    Abstract: The present disclosure provides methods of treating a subject having malignant mesothelioma, methods of identifying subjects having an increased risk of developing malignant mesothelioma, methods of detecting human Leucine-Rich Repeat Kinase 2 (LRRK2) variant nucleic acid molecules, and LRRK2 variant nucleic acid molecules.
    Type: Application
    Filed: April 20, 2022
    Publication date: June 13, 2024
    Inventors: Joseph R. Testa, Mitchell Cheung
  • Methods for diagnosing a predisposition to develop cancer
    Patent number: 10344333
    Abstract: Systems, methods, and computer readable media for diagnosing or characterizing a genetic predisposition to develop cancer are provided. Nucleic acids comprising a germline nucleic acid sequence encoding the BRCA1 associated protein 1 are sequenced or probed to determine if the nucleic acid sequence includes alterations that predispose a subject to develop cancer.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: July 9, 2019
    Assignees: Institute For Cancer Research, University of Hawaii
    Inventors: Joseph R. Testa, Michele Carbone, Mitchell Cheung, Jianming Pei
  • Systems and Methods for Diagnosing a Predisposition to Develop Cancer
    Publication number: 20140011699
    Abstract: Systems, methods, and computer readable media for diagnosing or characterizing a genetic predisposition to develop cancer are provided. Nucleic acids comprising a germline nucleic acid sequence encoding the BRCA1 associated protein 1 are sequenced or probed to determine if the nucleic acid sequence includes alterations that predispose a subject to develop cancer.
    Type: Application
    Filed: February 17, 2012
    Publication date: January 9, 2014
    Inventors: Joseph R. Testa, Michele Carbone, Mitchell Cheung, Jianming Pei
  • SYSTEMS AND METHODS FOR DIAGNOSING A PREDISPOSITION TO DEVELOP CANCER
    Publication number: 20140010802
    Abstract: Systems, methods, and computer readable media for diagnosing or characterizing a genetic predisposition to develop cancer, including cancers of the BAP1 cancer syndrome, are provided. Nucleic acids comprising a germline nucleic acid sequence encoding the BRCA1 associated protein 1 (BAP1) are sequenced or probed to determine if the nucleic acid sequence includes alterations that predispose a subject to develop cancer.
    Type: Application
    Filed: August 19, 2013
    Publication date: January 9, 2014
    Applicants: University of Hawaii, Office of Technology Transfer and Economic Development, Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center ("Fox Chase C
    Inventors: Joseph R. Testa, Michele Carbone, Mitchell Cheung, Jianming Pei